title: RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma.
abstract: OBJECTIVE
  The RigOR study was designed to assess comparative effectiveness of medications, laser trabeculoplasty and incisional surgery in patients with open-angle glaucoma (OAG) in the community initiating a new or additional course of therapy as judged necessary by their ophthalmologist. This paper focuses specifically on demographic and clinical characteristics of OAG patients at enrollment.
  
  
  METHODS
  A total of 2597 with OAG already on medical therapy were enrolled from 45 community and academic practices throughout the USA.
  
  
  RESULTS
  Overall, 784 (30%) patients were treated with laser surgery, 436 with other surgical procedures (17%), and 1377 with additional medication (53%). Patients had mild (35%) or moderate (31%) glaucoma, with 28% with severe glaucoma.
  
  
  CONCLUSIONS
  The RiGOR study enrolled a diverse population and will provide valuable information regarding visual function and treatment patterns among different racial/ethnic populations. African-American and Hispanic patients entered the study with poorer visual acuity and more severe glaucoma.
authors.affiliation: H. Dunbar Hoskins Jr, MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA.|Jules Stein Eye Institute, David Geffen School of Medicine & Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA.
authors.forename: Anne L
authors.initials: AL
authors.lastname: Coleman
authors.affiliation: H. Dunbar Hoskins Jr, MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA.
authors.forename: Flora C
authors.initials: FC
authors.lastname: Lum
authors.affiliation: Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, Cambridge, MA 02139, USA.
authors.forename: Priscilla
authors.initials: P
authors.lastname: Velentgas
authors.affiliation: Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, Cambridge, MA 02139, USA.
authors.forename: Daniel
authors.initials: D
authors.lastname: Campion
authors.affiliation: Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, Cambridge, MA 02139, USA.
authors.forename: Zhaohui
authors.initials: Z
authors.lastname: Su
authors.affiliation: Massachusetts Eye & Ear Infirmary & Harvard Medical School, Boston, MA 02114, USA.
authors.forename: Richard E
authors.initials: RE
authors.lastname: Gliklich
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy* / Q000628:therapy*; D006801:Humans; D053685:Laser Therapy / Q000379:methods; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D014130:Trabeculectomy / Q000379:methods; D016896:Treatment Outcome; D055815:Young Adult
keywords: comparative effectiveness; disparities; glaucoma medication; glaucoma surgery; open-angle glaucoma; registry